FIELD: biologically active peptides. SUBSTANCE: invention relates to derivatives of parent peptide GLP-1 having one or twp lipophilic substituents optionally connected to amino acid residue via amino acid or dipeptide spacer, said amino acid residue being no N-terminal or N- terminal amino acid residue and said parent peptide having following amino acid sequence: HAEGTFTSDVSSYLEGQAAKEEFIAWLVKGRG or having up to 1- amino acid residues in sum specified by any genetically encoded alpha-amino acid residue. Pharmaceutical compositions containing indicated derivatives as well as utilization thereof for preparing drug with prolonged obesity-treating activity are likewise described. EFFECT: prolonged activity profile with regard to GLP-1 (7-37). 74 cl, 2 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE COMPOSITION CONTAINING PROPYLENE GLYCOL OPTIMAL FOR MANUFACTURING AND APPLICATION IN INJECTION DEVICES | 2004 |
|
RU2421238C2 |
INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
CARBOHYDRATE-CONTAINING INSULIN PREPARATIONS | 1997 |
|
RU2204411C2 |
LIPOPHILIC DERIVATIVES OF PEPTIDE HORMONES | 1996 |
|
RU2171261C2 |
METHOD OF PEPTIDE ACIDIFYING | 2003 |
|
RU2345062C2 |
STABILISED PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE | 2004 |
|
RU2421236C2 |
METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
TREATING DIABETES MELLITUS BY INSULIN INJECTIONS AS LITTLE AS ONCE DAY | 2009 |
|
RU2540922C2 |
DOUBLE-ACYLATED GLP-1 DERIVATIVES | 2010 |
|
RU2559540C2 |
SOLID COMPOSITIONS CONTAINING AGONIST TO GLP AND SALT OF N-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2011 |
|
RU2600440C2 |
Authors
Dates
2003-10-20—Published
1997-08-22—Filed